Journal of Cancer Research and Clinical Oncology

, Volume 132, Issue 12, pp 817–823

MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays

  • Huachuan Zheng
  • Hiroyuki Takahashi
  • Takahiko Nakajima
  • Yoshihiro Murai
  • Zhengguo Cui
  • Kazuhiro Nomoto
  • Koichi Tsuneyama
  • Yasuo Takano
Original Paper



MUC6 was first discovered by screening a gastric mucosa cDNA library and is expressed in the mucous cells of the neck zone and antral glands of the stomach. The aim of the present study was to clarify whether down-regulation has any clinicopathological or prognostic significance in gastric neoplasia.


Expression of MUC6, MUC5AC and MUC2 was examined using tissue microarrays for immunohistochemistry in gastric carcinomas (n = 225), adenomas (n = 40), and normal mucosa (n = 89) and compared with clinicopathological parameters and survival data.


MUC6 expression was lower in gastric carcinomas than in adenomas or normal mucosa (P < 0.05) and inversely correlated with tumor size, depth of invasion, lymphatic and venous invasion, lymph node metastasis and UICC staging (P < 0.05). Positive links with expression of MUC2 and MUC5AC were noted (P < 0.05). MUC6 expression was lower in diffuse-type than intestinal-type lesions (P < 0.05). Kaplan–Meier analysis indicated that cumulative survival of patients with no MUC6 expression was significantly lower than with weak, moderate or strong expression in all and even advanced gastric carcinoma (P < 0.05). Multivariate analysis showed three independent prognostic factors, depth of invasion, lymphatic and venous invasion, to concordantly affect the relationship between MUC6 expression and prognosis.


Down-regulation of MUC6 may contribute to malignant transformation of gastric epithelial cells and underlie the molecular bases of growth, invasion, metastasis and differentiation of gastric carcinoma. Altered expression might therefore be employed as an indicator of pathobiological behaviors and prognosis of gastric carcinoma.


Mucin Gastric carcinoma Tumorigenesis Progression Prognosis Tissue microarray 


  1. Baldus SE, Monig SP, Arkenau V, Hanisch FG, Schneider PM, Thiele J, Holscher AH, Dienes HP (2002) Correlation of MUC5AC immunoreactivity with histopathological subtypes and prognosis of gastric carcinoma. Ann Surg Oncol 9:887–893PubMedGoogle Scholar
  2. Bartman AE, Buisine MP, Aubert JP, Niehans GA, Toribara NW, Kim YS, Kelly EJ, Crabtree JE, Ho SB (1998) The MUC6 secretory mucin gene is expressed in a wide variety of epithelial tissues. J Pathol 186:398–405PubMedCrossRefGoogle Scholar
  3. Byrd JC, Bresalier RS (2004) Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 23:77–99PubMedCrossRefGoogle Scholar
  4. Byrd JC, Yunker CK, Xu QS, Sternberg LR, Bresalier RS (2000) Inhibition of gastric mucin synthesis by Helicobacter pylori. Gastroenterology 118:1072–1079PubMedCrossRefGoogle Scholar
  5. Cozzi PJ, Wang J, Delprado W, Perkins AC, Allen BJ, Russell PJ, Li Y (2005) MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. Clin Exp Metastasis 22:565–573PubMedCrossRefGoogle Scholar
  6. Durai Babu S, Jayanthi V, Niranjali D, Reis CA, Devaraj H (2006) Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium. Mol Cancer 5:10 (in press)Google Scholar
  7. Hamamoto A, Abe Y, Nishi M, Fujimori S, Ohnishi Y, Yamazaki H, Oida Y, Miyazaki N, Inada K, Ueyama Y, Iwasaki M, Inoue H, Nakamura M (2005) Aberrant expression of the gastric mucin MUC6 in human pulmonary adenocarcinoma xenografts. Int J Oncol 26:891–896PubMedGoogle Scholar
  8. Ho SB, Shekels LL, Toribara NW, Kim YS, Lyftogt C, Cherwitz DL, Niehans GA (1995) Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res 55:2681–2690PubMedGoogle Scholar
  9. Ho SB, Takamura K, Anway R, Shekels LL, Toribara NW, Ota H (2004) The adherent gastric mucous layer is composed of alternating layers of MUC5AC and MUC6 mucin proteins. Dig Dis Sci 49:1598–606PubMedCrossRefGoogle Scholar
  10. zur Hausen A, van Grieken NC, Meijer GA, Hermsen MA, Bloemena E, Meuwissen SG, Baak JP, Meijer CJ, Kuipers EJ, van den Brule AJ (2001) Distinct chromosomal aberrations in Epstein-Barr virus-carrying gastric carcinomas tested by comparative genomic hybridization. Gastroenterology 121:612–618PubMedCrossRefGoogle Scholar
  11. Kim H, Seo JH, Kim KH (2003) The effect of p38 mitogen-activated protein kinase on mucin gene expression and apoptosis in Helicobacter pylori-infected gastric epithelial cells. Ann N Y Acad Sci 1010:90–94PubMedCrossRefGoogle Scholar
  12. Kocer B, Soran A, Kiyak G, Erdogan S, Eroglu A, Bozkurt B, Solak C, Cengiz O (2004) Prognostic significance of mucin expression in gastric carcinoma. Dig Dis Sci 49:954–64PubMedCrossRefGoogle Scholar
  13. Kodama M, Kodama T, Murakami M (2000) Oncogene activation and tumor suppressor gene inactivation find their sites of expression in the changes in time and space of the age-adjusted cancer incidence rate. In Vivo 14:725–734PubMedGoogle Scholar
  14. Kumada T, Tsuneyama K, Hatta H, Ishizawa S, Takano Y (2004) Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital. Mod Pathol 17:1141–1149PubMedCrossRefGoogle Scholar
  15. Lauren P (1965). The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49PubMedGoogle Scholar
  16. Lee HS, Lee HK, Kim HS, Yang HK, Kim YI, Kim WH (2001) MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer 92:1427–1434PubMedCrossRefGoogle Scholar
  17. Mizoshita T, Tsukamoto T, Nakanishi H, Inada K, Ogasawara N, Joh T, Itoh M, Yamamura Y, Tatematsu M (2003) Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. J Cancer Res Clin Oncol 129:727–734PubMedCrossRefGoogle Scholar
  18. Pinto-de-Sousa J, David L, Reis CA, Gomes R, Silva L, Pimenta A (2002) Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma. Virchows Arch 440:304–310PubMedCrossRefGoogle Scholar
  19. Pinto-de-Sousa J, Reis CA, David L, Pimenta A, Cardoso-de-Oliveira M (2004) MUC5B expression in gastric carcinoma: relationship with clinico-pathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6. Virchows Arch 444:224–230PubMedCrossRefGoogle Scholar
  20. Ranzani GN, Renault B, Pellegata NS, Fattorini P, Magni E, Bacci F, Amadori D (1993) Loss of heterozygosity and K-ras gene mutations in gastric cancer. Hum Genet 92:244–249PubMedCrossRefGoogle Scholar
  21. Reis CA, David L, Carvalho F, Mandel U, de Bolos C, Mirgorodskaya E, Clausen H, Sobrinho-Simoes M (2000) Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas. J Histochem Cytochem 48:377–388PubMedGoogle Scholar
  22. Rousseau K, Byrne C, Kim YS, Gum JR, Swallow DM, Toribara NW (2004) The complete genomic organization of the human MUC6 and MUC2 mucin genes. Genomics 83:936–939PubMedCrossRefGoogle Scholar
  23. Slomiany BL, Slomiany A (2003) Impedance of Helicobacter pylori lipopolysaccharide interference with gastric mucin synthesis by peroxisome proliferator-activated receptor gamma activation involves phosphatidylinositol 3-kinase/ERK pathway. IUBMB Life 55:97–102PubMedGoogle Scholar
  24. Slomiany BL, Slomiany A (2005) Up-regulation in endothelin-1 by Helicobacter pylori lipopolysaccharide interferes with gastric mucin synthesis via epidermal growth factor receptor transactivation. Scand J Gastroenterol 40:921–928PubMedCrossRefGoogle Scholar
  25. Sobin LH, Wittekind CH (2002) TNM classification of malignant tumors, 6th edn. Wiley, HobokenGoogle Scholar
  26. Tajima Y, Shimoda T, Nakanishi Y, Yokoyama N, Tanaka T, Shimizu K, Saito T, Kawamura M, Kusano M, Kumagai K (2001) Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology 61:212–220PubMedCrossRefGoogle Scholar
  27. Utsunomiya T, Yonezawa S, Sakamoto H, Kitamura H, Hokita S, Aiko T, Tanaka S, Irimura T, Kim YS, Sato E (1998) Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Clin Cancer Res 4:2605–2614PubMedGoogle Scholar
  28. Wang RQ, Fang DC (2006) Effects of Helicobacter pylori infection on mucin expression in gastric carcinoma and pericancerous tissues. J Gastroenterol Hepatol 21:425–431PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Huachuan Zheng
    • 1
    • 2
  • Hiroyuki Takahashi
    • 1
  • Takahiko Nakajima
    • 4
  • Yoshihiro Murai
    • 1
  • Zhengguo Cui
    • 3
  • Kazuhiro Nomoto
    • 1
  • Koichi Tsuneyama
    • 3
  • Yasuo Takano
    • 1
  1. 1.Department of Diagnostic Pathology, School of MedicineUniversity of ToyamaToyamaJapan
  2. 2.Department of Molecular BiologyLiaoning University of Traditional Chinese MedicineShenyangChina
  3. 3.Department of Diagnostic Pathology and 21st Century COE Program, School of MedicineUniversity of ToyamaToyamaJapan
  4. 4.Department of Diagnostic Pathology and Department of International Medicine (3), School of MedicineUniversity of ToyamaToyamaJapan

Personalised recommendations